This video is an advertising mini-doc and was made by the CannaReporter® Commercial and Marketing department.
SOMAÍ Pharmaceuticals is a leading EU-GMP European vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceutical extract portfolio.
SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of a few and the first European-based vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.
Michael Sassano, CEO of SOMAÍ, takes us on a tour through the company facilities in Portugal, explaining how he got into medicinal cannabis and how SOMAÍ was founded. He also shows how everything works inside SOMAÍ and unveils the future projects for the company.
Also featured Rita Barata, Chief Marketing Officer at SOMAÍ in Portugal, who explains what medicinal cannabis products are being developed and will be soon available for the patients.
Videographer: Renato Velasco
Editing and Post-Production: Alisson Basso
Coordination: Helena Solnado and Fernando Bandrés - [email protected]
© CannaReporter® 2024 - All rights reserved
The United States Department of Agriculture (USDA) recently released the “Hemp Research Needs Map” and announced a $10 million investment in hemp research through Oregon State University. The document focuses on the research needs of the hemp sector and recommends consortia and public-private partnerships to enhance the development of the area, in an attempt to follow and even catch up with China, France and even Russia, the largest producers of hemp in the world
🚨 Breaking News: German citizen faces prolonged detention in Russia over cannabis gum incident 🇩🇪⚖️ Patrick Schobel, 38, detained at St Petersburg airport, now awaits trial until at least April 15th for alleged drug trafficking. Despite offering to surrender his passport, Schobel's request for house arrest was denied. Stay tuned for updates on this developing story. #LegalIssues #cannabispolicy #humanrights 🚔🌿
🌿✨ Exciting news in Portugal's healthcare scene! Infarmed, I.P. has given the green light to three new cannabis derivatives, now available in pharmacies. Among them, a flower and two oral solutions! Read it all in CannaReporter #MedicalCannabis #HealthUpdates 🌿💊
🌿 The FDA's groundbreaking analysis on cannabis reclassification delved into social media posts from cannabis users. Learn how this comprehensive study is shaping the conversation around cannabis policy and therapeutic benefits.
#FDA #CannabisReclassification #SocialMediaAnalysis
IACM Patient Council will be making its debut at the upcoming UN Commission on Narcotic Drugs (CND) session in Vienna!
This historic moment marks a significant step towards ensuring equitable access to medicinal cannabis for patients worldwide. Stay tuned as our dedicated representatives champion patient rights on the global stage. 🌎💚
#IACM #PatientRights #UNSession"
🎄 🎅 Não podíamos despedir-nos de 2023 sem agradecer a todos os nossos leitores por este ano incrível ! 💚 🌟🌿 Que esta quadra de Natal seja repleta de amor e alegria e que 2024 seja um ano repleto de conquistas e realizações! 🌲🎁 #CannaNatal #FelizAnoNovo #Cannareporter
🎄 🎅 We couldn't say goodbye to 2023 without a note of gratitude to all our readers for this amazing year! 💚 🌟🌿 May this Christmas season be fulfilled with love and joy and may 2024 be a year replenished of achievements and accomplishments! 🌲🎁 #CannaNatal #HappyNewYear #cannareporter
Constellation Brands says goodbye to cannabis drinks, focusing on new opportunities. 🌿👋 Despite changes, they hold a strong position in Canopy Growth. 📈 Exciting times ahead! 🚀 #ConstellationBrands #CanopyGrowth #cannabis
🔍 Important Health Advisory: Curaleaf's Voluntary Recall 🌿🚨
Curaleaf has taken a responsible step by voluntarily recalling a batch of its cannabis trim due to potential Aspergillus contamination. While no incidents have been reported, it's crucial to prioritize your safety. The Arizona Department of Health has issued a warning, and Curaleaf is working diligently with distributors and retailers to remove affected products.
Learn more in our latest article, available in over 7 languages. 🌐
https://cannareporter.eu/en/2023/10/29/arizona-curaleaf-recalls-batch-of-cannabis-trim-due-to-possible-aspergillus-contamination/
#CuraleafRecall #CannabisSafety #AspergillusContamination #PatientSafety"
10 Years of Hope and Progress: Medical Cannabis Bike Tour's Journey to Fight Glioblastoma 🚲🌱
A decade ago, the Medical Cannabis Bike Tour embarked on a mission to raise funds for groundbreaking research on cannabinoids' potential in treating glioblastoma. Fast forward to 2023, and over 400,000 euros have been raised through bicycle tours across Europe. The result? The first independent clinical trial in Spain, utilizing Tilray Medical's cannabis preparations. Stay tuned for the latest developments in the fight against glioblastoma!
#MedicalCannabis #Glioblastoma #Research #CannabisInnovation #HopeForACure
🌿 Malta Grants Two Authorizations Taking a Pioneering Step in Cannabis Regulation 🇲🇹🌍
In a historic move, Malta has granted its first two cannabis association licenses! The ARUC is paving the way for responsible cannabis use and harm reduction. Find out more about this groundbreaking development in our latest article, available in over 7 languages. 🌐📜
#CannabisRegulation #MaltaCannabis #ARUC #CannabisCommunity #HarmReduction #BreakingBarriers
France's Ongoing Journey with Medicinal Cannabis: Hope and Hurdles 🇫🇷🌿
French Minister of Health, Aurélien Rousseau, reaffirms the continuation of the experimental medical cannabis project, bringing relief to 2,540 patients. While the experiment shows promise, there's no commitment to a wider program this year. European marketing authorizations are the key, expected in 2025.
In a recent session, Rousseau addressed the absence of budget allocation for the experiment in the 2024 Social Security Financing Bill. If authorization isn't granted by 2025, a 'compassionate use' plan is on the horizon, ensuring patient access to evolving medicines.
A collective statement signed by health professionals and committee deputies calls for official implementation in 2024, emphasizing the ethical necessity for patients.
Stay tuned with CannaReporter as France navigates the path to medicinal cannabis. 🌱 #MedicinalCannabis #FranceHealthcare"
An Exciting Milestone: The Official Monograph for Cannabis Flower Joins the European Pharmacopeia 🌼📚
The European Pharmacopeia now embraces the medicinal potential of cannabis. This historic inclusion signals a new era for cannabis in healthcare and beyond. 🌿🌍 #EuropeanPharmacopeia #CannabisMedicine
"Germany Takes a Green Step Forward: Bundestag started discussion on Legalization Bill 🌿🇩🇪 #CannabisLegalization #GermanyGreenlight
“Vamos continuar a insistir num modelo falhado e que apenas tem agravado problemas, (…) ou vamos finalmente tentar uma coisa diferente?” Palavras do deputado Moisés Ferreira, do Bloco de Esquerda, durante a conferência “Exposição à canábis na adolescência e saúde” que decorreu na Assembleia da República com a organização por parte do GAT Grupo de Ativistas em Tratamentos 📹
“Os últimos 125 anos de proibicionismo falharam, e falharam redondamente”, palavras de João Cotrim de Figueiredo, deputado e líder do partido Iniciativa Liberal na conferência “Exposição à canábis na adolescência e saúde”, que decorreu na Assembleia da República e que foi organizada pela Iniciativa de Cidadãos pela Canábis do GAT Grupo de Ativistas em Tratamentos. 📹
“Somos os únicos nesta ÁREA que temos a frontalidade de dizer que somos contra a legalização da canábis.”, palavras do deputado do Partido Político CHEGA Pedro dos Santos Frazão, no evento “Exposição à canábis na adolescência e saúde” promovido pelo GAT Grupo de Ativistas em Tratamentos e a decorrer na Assembleia da República !
